Form 4 for NVAX NOVAVAX INC
Accepted 2025-02-05 00:00:00 ET · period of report 2024-03-31 · accession 0001104659-25-009785 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-05 | 2024-03-31+ | NVAX | MCGLYNN MARGARET G | Dir | A - Grant | $8.50 | +4,698 | 13.2K | +55% | +$40.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-30 | A | A | 778 | $12.77 | 13,990 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-31 | A | A | 1,178 | $8.61 | 15,168 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-31 | A | A | 2,029 | $4.90 | 5,829 | D | — | — | |
| 4 | Common | Common Stock | 2024-06-30 | A | A | 713 | $13.93 | 13,212 | D | — | — |